Ceredex Value Advisors LLC Acquires Shares of 1,063,257 Hill-Rom Holdings, Inc. (HRC)

Ceredex Value Advisors LLC acquired a new position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,063,257 shares of the medical technology company’s stock, valued at approximately $92,503,000. Hill-Rom accounts for approximately 1.1% of Ceredex Value Advisors LLC’s portfolio, making the stock its 17th biggest holding. Ceredex Value Advisors LLC owned 1.60% of Hill-Rom at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. We Are One Seven LLC acquired a new stake in shares of Hill-Rom during the 4th quarter valued at about $188,000. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Hill-Rom during the 1st quarter valued at about $203,000. CAPROCK Group Inc. acquired a new stake in shares of Hill-Rom during the 4th quarter valued at about $211,000. Braun Stacey Associates Inc. acquired a new stake in shares of Hill-Rom during the 4th quarter valued at about $233,000. Finally, BancorpSouth Bank acquired a new stake in shares of Hill-Rom during the 4th quarter valued at about $241,000. Hedge funds and other institutional investors own 84.49% of the company’s stock.

Shares of Hill-Rom opened at $89.78 on Friday, Marketbeat reports. The company has a current ratio of 1.85, a quick ratio of 1.36 and a debt-to-equity ratio of 1.34. Hill-Rom Holdings, Inc. has a twelve month low of $87.60 and a twelve month high of $89.61. The company has a market capitalization of $5.81 billion, a P/E ratio of 23.26, a P/E/G ratio of 1.34 and a beta of 0.98.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, April 27th. The medical technology company reported $1.05 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.02 by $0.03. Hill-Rom had a return on equity of 20.18% and a net margin of 6.85%. The business had revenue of $710.50 million for the quarter, compared to the consensus estimate of $707.54 million. During the same period last year, the business earned $0.88 EPS. The firm’s revenue was up 4.7% compared to the same quarter last year. research analysts forecast that Hill-Rom Holdings, Inc. will post 4.62 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 29th. Investors of record on Friday, June 22nd will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, June 21st. Hill-Rom’s payout ratio is 20.73%.

HRC has been the subject of several research reports. ValuEngine upgraded Hill-Rom from a “hold” rating to a “buy” rating in a report on Friday, March 2nd. Needham & Company LLC reiterated a “buy” rating on shares of Hill-Rom in a report on Friday, January 26th. Zacks Investment Research upgraded Hill-Rom from a “hold” rating to a “buy” rating and set a $99.00 price target for the company in a report on Thursday, January 18th. KeyCorp reiterated a “buy” rating and set a $97.00 price target on shares of Hill-Rom in a report on Thursday, January 18th. Finally, Goldman Sachs initiated coverage on Hill-Rom in a report on Wednesday, April 4th. They set a “neutral” rating and a $85.00 price target for the company. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $94.00.

In related news, SVP Deborah Rasin sold 7,590 shares of the firm’s stock in a transaction that occurred on Thursday, April 12th. The stock was sold at an average price of $86.02, for a total value of $652,891.80. Following the transaction, the senior vice president now directly owns 14,028 shares of the company’s stock, valued at approximately $1,206,688.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.90% of the stock is currently owned by company insiders.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply